GENMEDS

Owners

Goods & Services

Pharmaceutical preparations, namely, single-administration gene therapy products for the treatment and long-term management of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders; gene therapy products for medical purposes, namely, pharmaceutical preparations for the treatment of metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders; therapeutic preparations comprising viral vectors for gene delivery; biopharmaceuticals for modifying genetic expression to treat chronic and inherited conditions, namely, metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders; injectable gene therapy products for use in treating metabolic, autoimmune, cardiovascular, or neurological disorders; biologics in the nature of pharmaceutical preparations for the treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders, and for the treatment of metabolic, autoimmune, cardiovascular, and neurological disorders; biological preparations for the prevention or treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders; injectable pharmaceutical preparations for treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders; long-duration medicines for treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious, and oncological diseases, and neurological disorders